Skip Navigation
QualityTool

American Society of Clinical Oncology (ASCO) 2007 Guideline Update: Recommendations for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer


Description

This table provides the American Society of Clinical Oncology's previous and current recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.

This table provides the previous (2004) and current (2007) recommendations for the following topics:

  • Is combined androgen blockade better than castration alone?
  • Does early androgen deprivation therapy (ADT) improve outcomes over deferred therapy?
  • Is intermittent ADT better than continuous ADT?
Links to the Tool:
This tool is available at:: http://www.asco.org/sites/www.asco.org/files/andro-sen_revisions_table_2.pdf (If you don't have the software to open this PDF, download free Adobe Acrobat Reader® software External Web Site Policy.)

Developer

American Society of Clinical Oncology

Funding Sources

American Society of Clinical Oncology


QualityTool Topic

asp:qt-topic-replace-me


Links to National Guideline Clearinghouse or National Quality Measures Clearinghouse:

This tool is derived from the following guideline in the National Guideline Clearinghouse (NGC): Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline:
http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=10808&string=

History

  • Release Date: 04/2007
  • Original Summary: 08/2007
Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.
QualityTool Classification
Patient Population:
IOM Domains of Quality:

Last updated: April 10, 2013.